AmeriCares Honors Fresenius Kabi USA with Power of Partnership Award

June 13, 2016

Stamford, Conn. – June 13, 2016 – AmeriCares presented its annual Power of Partnership Award to Fresenius Kabi USA today in recognition of the company’s outstanding commitment to helping disaster survivors and improving health care access around the world. Fresenius Kabi, which specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, is a committed supporter of AmeriCares emergency response and global health programs. The company provides valuable product donations that allow health workers to provide quality care.

AmeriCares President and CEO Michael J. Nyenhuis presented the award at the Healthcare Distribution Alliance’s (HDA), formerly known as the Healthcare Distribution Management Association (HDMA), Business and Leadership Conference in Colorado Springs, Colorado. AmeriCares and HDA created the Power of Partnership Award to recognize medical manufacturing and distribution organizations that have shown exceptional dedication to expanding access to care for disadvantaged populations.

“Fresenius Kabi’s commitment to AmeriCares has helped us improve health for patients in need in 80 countries,” Nyenhuis said. “Whether we are supporting U.S. clinics serving the uninsured or medical volunteers bringing quality health care to remote areas around the world, Fresenius Kabi is a valued partner.”

Fresenius Kabi has supported AmeriCares since 2010, when the company provided medicines for AmeriCares emergency response work in Haiti after a devastating earthquake. Fresenius Kabi has supported more than 400 volunteer medical outreach trips and donated enough medicine to fill more than 350,000 prescriptions for patients in need worldwide. In 2015, Fresenius Kabi expanded its support for AmeriCares U.S. Programs by becoming a sponsor of AmeriCares Mental Health Initiative. The program provides free prescription medicines for low-income patients living with mental illness across the United States.

“Fresenius Kabi is committed to ‘caring for life’ in every aspect of our business, and we see it as a privilege to support the vital work of AmeriCares and its network of volunteer medical teams,” said John Ducker, president and CEO for Fresenius Kabi USA. “We are honored to receive this recognition from AmeriCares and HDA; we share their passion and commitment to supporting access to care.”

HDA President and CEO John M. Gray said, “Our industry plays a pivotal role in assisting organizations such as AmeriCares to provide aid to those most in need. We are proud to recognize the commitment of Fresenius Kabi in helping the most critical populations, both in the U.S. and abroad.”

About AmeriCares
AmeriCares is an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis in the United States and around the world. Every day, AmeriCares puts critically needed medicines and supplies in the hands of frontline health workers and develops innovative, sustainable health improvements in their communities. For more information, visit

About the Healthcare Distribution Alliance
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues. For more information, visit

About Fresenius Kabi
Fresenius Kabi ( is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. For more information about Fresenius Kabi worldwide, please visit


Media Contact
Matt Kuhn